CrosSmit schreef op 28 mei 2020 16:33:
[...]
2020-01013 4-5-2020 approved
Compassionate use of recombinant human C1 esterase inhibitor (Conestat alfa) in the prevention of clinical deterioration in high-risk subjects with COVID-19 pneumonia: a case series and matched case-control analysis monocentric
PD Dr. med. Michael Osthoff
University Hospital Basel, Basel personal data/biological material
Risk category is nu leeg ipv C